$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
How long does it take to take Tazetostat to achieve the best effect?
2026-02-01 22:25:32
Check Details
Analysis of the correct way to take ceritinib/ceritinib (Zanda) and daily precautions
2026-02-01 22:25:32
Check Details
Differences in dosages of besotivan (Vileri) for different tumor treatments and reference for individualized medication
2026-02-01 22:25:32
Check Details
Dabrafenib (Tefila) belongs to which generation of targeted drugs and its clinical significance
2026-02-01 22:25:32
Check Details
Analysis of the types of diseases treated by Axitinib (Inlida) and the specific conditions for which it is applicable
2026-02-01 22:25:32
Check Details
Analysis of the clinical efficacy of dual-target therapy combined with trametinib (Megenin) and dabrafenib
2026-02-01 22:25:32
Check Details
Does avatrombopag (Sucoxin) have to be used for a long time once it is taken?
2026-02-01 22:25:32
Check Details
Which type of leukemia does Giritinib (Segatan) mainly treat and its indications?
2026-02-01 22:25:32
Check Details
Is it necessary to continue taking pirfenidone (Asri) after taking it and suggestions for discontinuing the drug?
2026-02-01 22:25:32
Check Details
Canafenib/Encofenib is developed and produced by which pharmaceutical company and its background introduction
2026-02-01 22:25:32
Check Details
Is there any domestic drug for Imatinib and analysis of its price and availability?
2026-02-01 22:25:32
Check Details
Correct application method and daily usage instructions for ruxolitinib cream (Opzelura)
2026-02-01 22:25:32
Check Details
1
2
...
2044
2045
2046
2047
2048
2049
2050
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma